List of Tables
Table 1. Global Radioligand Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Actinium 225 (Ac-225)
Table 3. Key Players of Lutetium 177 (Lu-177)
Table 4. Key Players of Gallium 68 (Ga-68)
Table 5. Key Players of Fluorine 18 (F-18)
Table 6. Key Players of Other Radionuclides
Table 7. Global Radioligand Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Radioligand Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Radioligand Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Radioligand Therapy Market Share by Region (2020-2025)
Table 11. Global Radioligand Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Radioligand Therapy Market Share by Region (2026-2031)
Table 13. Radioligand Therapy Market Trends
Table 14. Radioligand Therapy Market Drivers
Table 15. Radioligand Therapy Market Challenges
Table 16. Radioligand Therapy Market Restraints
Table 17. Global Radioligand Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Radioligand Therapy Market Share by Players (2020-2025)
Table 19. Global Top Radioligand Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioligand Therapy as of 2024)
Table 20. Ranking of Global Top Radioligand Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Radioligand Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Radioligand Therapy, Headquarters and Area Served
Table 23. Global Key Players of Radioligand Therapy, Product and Application
Table 24. Global Key Players of Radioligand Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioligand Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Radioligand Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Radioligand Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Radioligand Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Radioligand Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Radioligand Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Radioligand Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Radioligand Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Radioligand Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Radioligand Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Radioligand Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Radioligand Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Radioligand Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Radioligand Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Novartis Company Details
Table 50. Novartis Business Overview
Table 51. Novartis Radioligand Therapy Product
Table 52. Novartis Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Advanced Accelerator Applications Company Details
Table 55. Advanced Accelerator Applications Business Overview
Table 56. Advanced Accelerator Applications Radioligand Therapy Product
Table 57. Advanced Accelerator Applications Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 58. Advanced Accelerator Applications Recent Development
Table 59. Mercy Radiology Company Details
Table 60. Mercy Radiology Business Overview
Table 61. Mercy Radiology Radioligand Therapy Product
Table 62. Mercy Radiology Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 63. Mercy Radiology Recent Development
Table 64. POINT Biopharma Global Inc Company Details
Table 65. POINT Biopharma Global Inc Business Overview
Table 66. POINT Biopharma Global Inc Radioligand Therapy Product
Table 67. POINT Biopharma Global Inc Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 68. POINT Biopharma Global Inc Recent Development
Table 69. Fusion Pharma Company Details
Table 70. Fusion Pharma Business Overview
Table 71. Fusion Pharma Radioligand Therapy Product
Table 72. Fusion Pharma Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 73. Fusion Pharma Recent Development
Table 74. Telix Pharmaceuticals Ltd Company Details
Table 75. Telix Pharmaceuticals Ltd Business Overview
Table 76. Telix Pharmaceuticals Ltd Radioligand Therapy Product
Table 77. Telix Pharmaceuticals Ltd Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 78. Telix Pharmaceuticals Ltd Recent Development
Table 79. Lantheus Holdings, Inc Company Details
Table 80. Lantheus Holdings, Inc Business Overview
Table 81. Lantheus Holdings, Inc Radioligand Therapy Product
Table 82. Lantheus Holdings, Inc Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 83. Lantheus Holdings, Inc Recent Development
Table 84. Bayer AG Company Details
Table 85. Bayer AG Business Overview
Table 86. Bayer AG Radioligand Therapy Product
Table 87. Bayer AG Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 88. Bayer AG Recent Development
Table 89. Curium Pharma Company Details
Table 90. Curium Pharma Business Overview
Table 91. Curium Pharma Radioligand Therapy Product
Table 92. Curium Pharma Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 93. Curium Pharma Recent Development
Table 94. Precirix Company Details
Table 95. Precirix Business Overview
Table 96. Precirix Radioligand Therapy Product
Table 97. Precirix Revenue in Radioligand Therapy Business (2020-2025) & (US$ Million)
Table 98. Precirix Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Radioligand Therapy Picture
Figure 2. Global Radioligand Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radioligand Therapy Market Share by Type: 2024 VS 2031
Figure 4. Actinium 225 (Ac-225) Features
Figure 5. Lutetium 177 (Lu-177) Features
Figure 6. Gallium 68 (Ga-68) Features
Figure 7. Fluorine 18 (F-18) Features
Figure 8. Other Radionuclides Features
Figure 9. Global Radioligand Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Radioligand Therapy Market Share by Application: 2024 VS 2031
Figure 11. Neuroendocrine Neoplasms Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Radioligand Therapy Report Years Considered
Figure 14. Global Radioligand Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Radioligand Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Radioligand Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Radioligand Therapy Market Share by Players in 2024
Figure 18. Global Top Radioligand Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioligand Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Radioligand Therapy Revenue in 2024
Figure 20. North America Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Radioligand Therapy Market Share by Country (2020-2031)
Figure 22. United States Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Radioligand Therapy Market Share by Country (2020-2031)
Figure 26. Germany Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Radioligand Therapy Market Share by Region (2020-2031)
Figure 34. China Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Radioligand Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Radioligand Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Radioligand Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Novartis Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 50. Advanced Accelerator Applications Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 51. Mercy Radiology Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 52. POINT Biopharma Global Inc Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 53. Fusion Pharma Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 54. Telix Pharmaceuticals Ltd Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 55. Lantheus Holdings, Inc Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 57. Curium Pharma Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 58. Precirix Revenue Growth Rate in Radioligand Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
